Evaluation of peripheral nerve stimulation as an alternative to radiofrequency ablation for facet joint pain
周围神经刺激替代射频消融治疗小关节疼痛的评估
基本信息
- 批准号:10734693
- 负责人:
- 金额:$ 51.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdverse effectsAffectAftercareAnesthesia proceduresArthralgiaAtrophicBackBack PainBiomechanicsClinicalControl GroupsDenervationElectric StimulationEvaluationFacet joint structureFatty acid glycerol estersFunctional disorderFutureGait speedHardnessImplantInfiltrationInjectionsIntervertebral disc structureLow Back PainMRI ScansMeasuresMedialModulusMotorMuscleNerveNerve BlockOperative Surgical ProceduresOutcomePainPatient Self-ReportPatientsPerformancePeripheral Nerve StimulationPlayProceduresProductionProtocols documentationRadiofrequency Interstitial AblationReportingRiskRoleRotationSignal TransductionSpinalSpinal FusionStenosisSystemTherapeutic InterventionTherapeutic UsesTissuesVertebral columnarmchronic back painelastographyinterestintervertebral disk degenerationnovelpain patientpain reductionpain reliefpreservationrandomized, clinical trialsrecruittissue mappingultrasound
项目摘要
Project Summary
It is estimated that 15% to 40% of chronic back pain cases involve the facet joints. Radiofrequency ablation
(RFA) of the medial branch nerve is a widely used therapeutic intervention that is very effective in reducing facet
joint pain. However, the medial branch nerve also provides motor signals to the multifidus muscle. Therefore, an
unavoidable consequence of RFA is denervation of the multifidus. The multifidus muscle spans 2 to 4 spine
levels, contributing significantly to the active, segmental stability of the spine. Recent reports have shown short-
term adverse effects on the multifidus muscle following RFA, including multifidus atrophy and increased fat
infiltration. Multifidus dysfunction causes abnormal loading and deformations of the intervertebral disc, leading
to accelerated disc degeneration at the treated level. Patients also have 2 to 5 times increased risk of developing
stenosis and other degenerative spine conditions or receiving a spine fusion in the 5 to 10 years after RFA,
compared to other low-back pain patients. Therefore, although RFA is beneficial in the short term, it may
predispose patients to other mechanisms of back pain in the future.
A recently approved treatment for facet joint pain is peripheral nerve stimulation (PNS) of the medial branch. In
this treatment, 1 or 2 fine‐wire leads are implanted near the medial nerve and connected to a wearable electrical
stimulator. The system enables continuous delivery of electrical stimulation to the medial nerves for 40 days.
After this period, the wires are removed. A recent study showed pain reduction of 70% lasting for up to 1 year,
which is comparable to RFA for the medial nerve. However, the effect of PNS on the function of the multifidus
muscle is known. Since the medial nerve is not damaged, it may be possible that motors signals still activate the
multifidus preserving part or all its functionality. If the multifidus retains it functionality after PNS, the adverse
effects observed after RFA could also be avoided. Therefore, the objective of this randomized clinical trial is to
compare clinical outcomes and adverse biomechanical effects between RFA and PNS for facet joint pain. The
study is divided in two aims. Aim 1 is to compare clinical and performance outcomes between RFA and PNS.
Aim 2 is to quantify and compare biomechanical effects of RFA and PNS.
Multifidus-sparing treatments for facet joint pain are of great interest. The multifidus muscle plays an important
role in spine biomechanics. Consequently, multifidus denervation can lead to other mechanisms of spine
degeneration and back pain. PNS is a promising alternative to RFA from the clinical point of view. This study will
not only compare clinical outcomes between RFA and PNS, but also look at potential adverse effects in terms
of spine biomechanics. If PNS doesn’t affect the multifidus function or increases the risk of spine degeneration,
it can greatly change the current approach for treatment of facet joint pain.
项目概要
据估计,15% 至 40% 的慢性背痛病例涉及小关节。
内侧支神经 (RFA) 是一种广泛使用的治疗干预措施,对于减少小关节面积非常有效
然而,内侧支神经也向多裂肌提供运动信号。
RFA 不可避免的后果是多裂肌的去神经支配 多裂肌跨越 2 至 4 个脊柱。
水平,对脊柱的主动、节段稳定性有显着贡献。最近的报告显示,
RFA 后对多裂肌的长期不良影响,包括多裂肌萎缩和脂肪增加
多裂肌浸润功能障碍导致椎间盘的异常负载和变形,导致
在治疗水平上,患者发生椎间盘退变的风险也会增加 2 至 5 倍。
RFA 后 5 至 10 年内出现狭窄和其他脊柱退行性疾病或接受脊柱融合术,
因此,与其他腰痛患者相比,虽然 RFA 在短期内是有益的,但它可能会带来副作用。
使患者将来容易出现其他背痛机制。
最近批准的治疗小关节疼痛的方法是内侧分支的周围神经刺激(PNS)。
在这种治疗中,将 1 或 2 根细导线植入内侧神经附近,并连接到可穿戴电子设备
该系统能够连续向内侧神经提供 40 天的电刺激。
在此期间之后,移除金属丝,最近的一项研究表明,疼痛减轻了 70%,可持续长达 1 年。
这与内侧神经的 RFA 相当,但是 PNS 对多裂肌功能的影响。
由于内侧神经未受损,运动信号可能仍会激活肌肉。
如果多裂肌在 PNS 后保留其功能,则不利。
RFA 后观察到的影响也是可以避免的,因此,这项随机临床试验的目的是
比较 RFA 和 PNS 治疗小关节疼痛的临床结果和不良生物力学效应。
研究分为两个目的,目的 1 是比较 RFA 和 PNS 的临床和表现结果。
目标 2 是量化和比较 RFA 和 PNS 的生物力学效应。
多裂肌对于小关节疼痛的保留治疗非常重要。
经测试,多裂肌去神经可以导致脊柱的其他机制。
从临床角度来看,PNS 是 RFA 的一种有前景的替代方案。
不仅比较 RFA 和 PNS 的临床结果,而且还考虑潜在的不良反应
如果 PNS 不影响多裂肌功能或增加脊柱退化的风险,
它可以极大地改变目前治疗小关节疼痛的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Humberto Cortes Correales其他文献
Daniel Humberto Cortes Correales的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Humberto Cortes Correales', 18)}}的其他基金
Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation
神经肌肉电刺激用于跟腱断裂康复
- 批准号:
10400154 - 财政年份:2021
- 资助金额:
$ 51.42万 - 项目类别:
Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation
神经肌肉电刺激用于跟腱断裂康复
- 批准号:
10619528 - 财政年份:2021
- 资助金额:
$ 51.42万 - 项目类别:
continuous shear wave elastography as a diagnostic marker for tendinopathy
连续剪切波弹性成像作为肌腱病的诊断标志物
- 批准号:
9014519 - 财政年份:2015
- 资助金额:
$ 51.42万 - 项目类别:
continuous shear wave elastography as a diagnostic marker for tendinopathy
连续剪切波弹性成像作为肌腱病的诊断标志物
- 批准号:
8808800 - 财政年份:2015
- 资助金额:
$ 51.42万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Aortic stiffness, wave reflection, and cerebrovascular flow pulsatility: relations with brain small vessel disease and cognitive function in a middle-aged cohort
主动脉僵硬度、波反射和脑血管血流搏动:与中年队列中脑小血管疾病和认知功能的关系
- 批准号:
10662819 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别: